Farmakokinetiske data fra undersøgelsen antyder, at distributionsvolumet og clearance af bevacizumab er sammenlignelig med den for voksne med solide tumorer.
The resulting pharmacokinetic data suggest that the volume of distribution and clearance of bevacizumab were comparable to that in adults with solid tumours.